Plasma proteomic evidence for increased β-amyloid pathology after SARS-CoV-2 infection
UK study of 1,252 people finds SARS-CoV-2 may accelerate Alzheimer’s-related brain changes.
Infected individuals showed shifts in key biomarkers, with greater effects in hospitalized patients and those with hypertension.